Business profile

NextPharma Oy

NextPharma Oy's registered office is Tampere. It is a limited company. The company was established on 2019-01-24. It operates in the industry of manufacture of pharmaceutical preparations. In its latest retained statement for 2024-12-31, revenue was €31,346,784 and operating profit was €1,106,513.

Business ID 2968177-8ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
2968177-8
Sector
Manufacture of pharmaceutical preparations
Municipality
Tampere
Company form
Limited company
Registration date
2019-01-24
Business ID registration date
2019-01-16
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Niittyhaankatu 20, 33720, Tampere

People and decision-makers

Enjeti Ajeeth KumarToimitusjohtaja

About NextPharma Oy

Financial position and key figures for the company.

NextPharma Oy's location municipality is Tampere. It is a limited company. The company was established on 2019-01-24. It operates in the industry of manufacture of pharmaceutical preparations. In its latest retained statement for 2024-12-31, revenue was €31,346,784 and operating profit was €1,106,513. The latest retained financial statement for 2024-12-31 shows revenue of €31,346,784 and profit for the financial year of €60,130. Based on the latest retained statement, revenue growth was +4.6%, operating margin was +3.5%, and equity ratio was +31.4%.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2024-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth4.6%
Operating margin3.5%
Equity ratio31.4%
Revenue€31,346,784+€1,388,628 (+4.6%) vs previous periodPrevious: €29,958,156
Operating profit (loss)€1,106,513-€448,160 (-28.8%) vs previous periodPrevious: €1,554,672
Profit (loss) for the financial year€60,130+€1,063,245 (+106.0%) vs previous periodPrevious: -€1,003,115
Assets€36,895,314+€6,187,400 (+20.1%) vs previous periodPrevious: €30,707,914
Balance-sheet contextLatest financial period
Profit before taxes€545,730Previous: €876,487
Employees225Previous: 189
Revenue trend4 periods
€24,524,327
2021-12-31
€30,189,751
2022-12-31
€29,958,156
2023-12-31
€31,346,784
2024-12-31
Operating profit (loss) trend4 periods
€3,152,979
2021-12-31
€13,390,034
2022-12-31
€1,554,672
2023-12-31
€1,106,513
2024-12-31
Profit (loss) for the financial year trend4 periods
€1,694,941
2021-12-31
€6,320,210
2022-12-31
-€1,003,115
2023-12-31
€60,130
2024-12-31
Assets trend4 periods
€25,150,424
2021-12-31
€36,716,154
2022-12-31
€30,707,914
2023-12-31
€36,895,314
2024-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioSatisfactory
39/100 · Declining
31.4 %2023-12-31: 37.5 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2023-12-31: Ei saatavilla
Operating profit marginSatisfactory
59/100 · Declining
3.5 %2023-12-31: 5.2 %
Ratio history
Ratio2021-12-312022-12-312023-12-312024-12-31
Equity ratio24.7 %34.1 %37.5 %31.4 %
Current ratio----
Operating profit margin12.8 %44.1 %5.2 %3.5 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID2968177-8
VAT IDFI29681778
EU IDFIFPRO.2968177-8
MunicipalityTampere
Current registered entries
2019-01-16Registered in Tax Administration (Employer Register)
2019-01-16VAT-liable for business activity in Tax Administration (VAT Register)
2019-01-16Registered in Tax Administration (Prepayment Register)
2019-01-24Registered in Tax Administration (Tax Administration)
2019-01-24Registered in Patent and Registration Office (Trade Register)
2020-04-01VAT-obliged for the transfer of rights to use immovable property in Tax Administration (VAT Register)

Responsible people

Public role relationships materialized from source observations.

Enjeti Ajeeth KumarToimitusjohtajaSources: 4 · Confidence: 78%
Ajeeth Kumar EnjetiHallituksen puheenjohtaja (4/2026)Sources: 2 · Confidence: 76%
Sinkkonen Otto Aki JuhaniProkuristiSources: 1 · Confidence: 78%
Särkkä Satu Tiina MarjaanaProkuristiSources: 1 · Confidence: 78%
Schmidhäuser Eric CarstenVarsinainen jäsenSources: 3 · Confidence: 78%
Hawkins William MarkVarsinainen jäsenSources: 3 · Confidence: 78%
Mäkinen Arttu-Pekka OskariProkuristiSources: 1 · Confidence: 78%
Salminen Ulla IrmeliProkuristiSources: 1 · Confidence: 78%
Weber Stefan SanderProkuristiSources: 1 · Confidence: 78%
Zachari Edwin-OswaldProkuristiSources: 1 · Confidence: 78%
Miikka HietalaPäävastuullinen tilintarkastajaSources: 1 · Confidence: 76%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B1
StableNextPharma Oy
Model score66/100
Assessment confidenceMedium
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators have weakened across comparable fiscal periods.
4 comparable periods
RevenueStable
ProfitabilityDeteriorating
SolvencyDeteriorating
LiquidityNot enough history
Supporting factors
  • Active registered status
  • A newer financial statement filing has been reported
Risk factors to note
  • Coordinated deterioration across 2 financial domains
Automatic model gradeB1
Automatic model snapshot2026-10-07
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskmedium
68/100

Industry context is medium based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 7 years of registry continuity.

Registry and status signalsSeurattava
71/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
7 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

22 register eventsLatest event: 2026-04-01

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2026-04-01.

This company profile has not been claimed yet

NextPharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.